Skip to Content

Genetics Hall of Fame


Guillermina Lozano, Ph.D.
Raycroft L, Wu HY, Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. (1990) Science  249 (4972) 1049-51


Richard R. Behringer, Ph.D.
Shawlot W, Behringer RR. (1995) Requirement for Lim1 in head-organizer function. Nature 374(6521):425-430 


Benoit DeCrombrugghe, M.D.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29


Dr. Guillermina Lozano elected to the Institute of Medicine (IOM) of the National Academies

Gigi Lozano, Ph.D.
Chair & Professor

Dr. Lozano is now one of nine MD Anderson faculty members in the IOM. She was recognized for her work on the p53 tumor suppressor pathway, specifically in regards to understanding the role of p53 mutants in tumorigenesis and the roles of Mdm2 and Mdm4 as inhibitors of p53.

Recipient of the R. Lee Clark Fellowship

Michael Galko, Ph.D.
Assistant Professor

This prestigious new award program recognizes and supports 16 MD Anderson junior faculty members whose early excellence indicates they will become future leaders. The program is named in honor of MD Anderson’s first president, R. Lee Clark.

2014 MD Anderson Internal “Knowledge Gaps”Grant Awardees

Guillermina "Gigi" Lozano, Ph.D., Professor and Chair
“Mechanisms of oncogenesis and metastasis with potential for translation”

Nicholas Navin, Assistant Professor
“Investigating metastasis and non-invasive monitoring in TNBC by single-cell sequencing”

Drs. Lozano and Navin were awarded $100,000 each from MD Anderson to support their efforts to fill the “knowledge gaps” that limit our ability to prevent, detect or treat cancer.

© 2015 The University of Texas MD Anderson Cancer Center